Decentralizing FDA Regulation
Balaji and Jason discuss the need to decentralize FDA regulation and create alternate regulatory pathways at the state level, allowing for more experimentation and innovation in healthcare. They highlight the potential benefits of different regions adopting their own regulatory regimes and the importance of intelligence in the system.In this clip
From this podcast
This Week in Startups
E1042 Balaji Srinivasan on Recode incident, techlash history, potential COVID-19 endgames & more
Related Questions